JEROME J. DVONCH - 20 Jun 2024 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Financial Officer
Signature
/s/ Jerome Dvonch
Issuer symbol
SNOA
Transactions as of
20 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 17:05:40 UTC
Previous filing
29 Dec 2023
Next filing
03 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNOA Common Stock, $0.0001 par value Award +53,586 +173% 84,595 20 Jun 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock were awarded and granted as Restricted Stock Units to Mr. Dvonch for services performed as part of the Company's annual bonus compensation to executives. The shares vested in full on the grant date.